BSE & NSE filings
Financial results announcements
What listed companies told the exchanges — order wins, results, acquisitions, fundraises, capex and ratings — read from each filing and written up in three points. Updated every night.
← All filings · Each filing is rated by what it means for the business; routine filings get no page.
- WeWork India Management Limited approves Q1 FY27 results, capital restructuring
- Piramal Finance approves Q1 FY27 results, board clears up to Rs. 4,000 crore fund raise
- Glenmark Pharmaceuticals reports audited Q4 and FY26 results with dividend recommendation
- InterGlobe Aviation reports standalone loss before tax of Rs. 20,833 million for FY2026
- AXISCADES Technologies Ltd announces audited Q4 and FY26 results and ₹20 crore guarantee
- AXISCADES Technologies Limited announces audited Q4 and FY 2026 financial results
- PC Jeweller Ltd approves FY26 audited results; board approves MD re-appointment
- Aditya Infotech Limited announces audited FY26 results, dividend, and Taiwan investment
- E.I.D. - Parry (India) Limited announces audited financial results for FY 2026
- IDream Film Infrastructure approves audited financial results for FY 2025-26
- Precision Wires India reports audited results for quarter and year ended 31 March 2026
- Sarda Energy & Minerals Ltd announces FY 2025-26 audited financials and expansion plan
- NTPC Green Energy Limited submits audited financial results and disclosures for FY 2025-26
- JSW Cement Limited reports FY2026 audited results, 2.5 MTPA Nagaur capacity addition
- Welspun Corp approves FY26 audited results, 100% final dividend and CleanMax stake sale
- Sammaan Capital posts ₹8,101.41 crore Q4 consolidated loss; audited FY26 results
- HealthCare Global Enterprises approves audited FY2025-26 results and BACC divestment
- Trident Q4 FY26 profit INR 1,019.8 million; interim dividend INR 0.50 declared
- PI Industries approves FY2025-26 audited results and recommends Rs 10 final dividend
- Mankind Pharma approves Q4 and FY26 results, ₹500 crore subsidiary investment
- Mankind Pharma: FY26 results, director re-appointment, ₹500 crore subsidiary investment
- KEC International reports audited results for quarter and year ended March 31, 2026
- Vodafone Idea Limited announces audited financial results for FY ending March 31, 2026
- Balrampur Chini Mills approves FY 2025-26 audited results and re-appoints two directors
- Balrampur Chini Mills Ltd announces audited FY 2025-26 results and board changes
- Devyani International Limited announces audited financial results for FY 2025-26
- Welspun Living FY26 results, ₹252 crore buyback, Re 0.10 dividend, director change
- KRN Heat Exchanger announces audited FY2026 results and key managerial changes
- Welspun Enterprises Ltd approves FY 2026 financial results and proposes dividend
- Welspun Enterprises announces FY 2026 audited results, dividend, board changes
Summaries are written by Arthneeti from each company's exchange filing; the original PDF is linked on every page. Research and analytics only — not investment advice.